124 related articles for article (PubMed ID: 28439877)
1. Increased non-relapse mortality due to high-dose cytarabine plus CY/TBI in BMT/PBSCT for acute lymphoblastic leukaemia in adults.
Arai Y; Kondo T; Shigematsu A; Tanaka J; Ohashi K; Fukuda T; Kawakita T; Mori T; Hoshino T; Onizuka M; Ozawa Y; Yoshida S; Ueda Y; Mizuno I; Atsuta Y; Mizuta S;
Br J Haematol; 2017 Jul; 178(1):106-111. PubMed ID: 28439877
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of high-dose cytarabine added to cyclophosphamide/total-body irradiation in bone marrow or peripheral blood stem cell transplantation for myeloid malignancy.
Arai Y; Aoki K; Takeda J; Kondo T; Eto T; Ota S; Hashimoto H; Fukuda T; Ozawa Y; Kanda Y; Kato C; Kurokawa M; Iwato K; Onizuka M; Ichinohe T; Atsuta Y; Takami A;
J Hematol Oncol; 2015 Sep; 8():102. PubMed ID: 26337829
[TBL] [Abstract][Full Text] [Related]
3. Significance of Granulocyte Colony-Stimulating Factor-Combined High-Dose Cytarabine, Cyclophosphamide, and Total Body Irradiation in Allogeneic Hematopoietic Cell Transplantation for Myeloid Malignant Neoplasms.
Nakamura Y; Tanaka Y; Tanaka M; Yamamoto K; Matsuguma M; Kajimura Y; Tokunaga Y; Yujiri T; Tanizawa Y
Transplant Proc; 2019 Apr; 51(3):896-900. PubMed ID: 30979482
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of total body irradiation, cyclophosphamide, and cytarabine as a conditioning regimen for allogeneic hematopoietic stem cell transplantation in patients with acute lymphoblastic leukemia.
Mori T; Aisa Y; Kato J; Yamane A; Nakazato T; Shigematsu N; Okamoto S
Am J Hematol; 2012 Apr; 87(4):349-53. PubMed ID: 22290459
[TBL] [Abstract][Full Text] [Related]
5. High-dose cytarabine added to CY/TBI improves the prognosis of cord blood transplantation for acute lymphoblastic leukemia in adults: a retrospective cohort study.
Arai Y; Kondo T; Shigematsu A; Tanaka J; Takahashi S; Kobayashi T; Uchida N; Onishi Y; Ishikawa J; Kanamori H; Sawa M; Yokota A; Kouzai Y; Takanashi M; Ichinohe T; Atsuta Y; Mizuta S
Bone Marrow Transplant; 2016 Dec; 51(12):1636-1639. PubMed ID: 27643870
[No Abstract] [Full Text] [Related]
6. Efficiency of high-dose cytarabine added to CY/TBI in cord blood transplantation for myeloid malignancy.
Arai Y; Takeda J; Aoki K; Kondo T; Takahashi S; Onishi Y; Ozawa Y; Aotsuka N; Kouzai Y; Nakamae H; Ota S; Nakaseko C; Yamaguchi H; Kato K; Atsuta Y; Takami A;
Blood; 2015 Jul; 126(3):415-22. PubMed ID: 26031916
[TBL] [Abstract][Full Text] [Related]
7. Total body irradiation compared with BEAM: Long-term outcomes of peripheral blood autologous stem cell transplantation for non-Hodgkin's lymphoma.
Liu HW; Seftel MD; Rubinger M; Szwajcer D; Demers A; Nugent Z; Schroeder G; Butler JB; Cooke A
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):513-20. PubMed ID: 20137862
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic bone marrow transplantation for acute lymphoblastic leukaemia: risk factors and clinical outcome.
Weisdorf DJ; Woods WG; Nesbit ME; Uckun F; Dusenbery K; Kim T; Haake R; Thomas W; Kersey JH; Ramsay NK
Br J Haematol; 1994 Jan; 86(1):62-9. PubMed ID: 8011550
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Cyclophosphamide Combined with Total Body Irradiation, Oral Busulfan, or Intravenous Busulfan for Allogeneic Hematopoietic Cell Transplantation in Adults with Acute Lymphoblastic Leukemia.
Mitsuhashi K; Kako S; Shigematsu A; Atsuta Y; Doki N; Fukuda T; Kanamori H; Onizuka M; Takahashi S; Ozawa Y; Kurokawa M; Inoue Y; Nagamura-Inoue T; Morishima Y; Mizuta S; Tanaka J;
Biol Blood Marrow Transplant; 2016 Dec; 22(12):2194-2200. PubMed ID: 27638362
[TBL] [Abstract][Full Text] [Related]
10. Comparison of transplant outcomes from matched sibling bone marrow or peripheral blood stem cell and unrelated cord blood in patients 50 years or older.
Konuma T; Tsukada N; Kanda J; Uchida N; Ohno Y; Miyakoshi S; Kanamori H; Hidaka M; Sakura T; Onizuka M; Kobayashi N; Sawa M; Eto T; Matsuhashi Y; Kato K; Ichinohe T; Atsuta Y; Miyamura K;
Am J Hematol; 2016 May; 91(5):E284-92. PubMed ID: 26910296
[TBL] [Abstract][Full Text] [Related]
11. Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission: factors predictive of survival, relapse and graft-versus-host disease.
Moussalem M; Esperou Bourdeau H; Devergie A; Baruchel A; Ribaud P; Socie G; Parquet N; Traineau R; Hirsch I; Schaison G
Bone Marrow Transplant; 1995 Jun; 15(6):943-7. PubMed ID: 7581095
[TBL] [Abstract][Full Text] [Related]
12. Significance of additional high-dose cytarabine in combination with cyclophosphamide plus total body irradiation regimen for allogeneic stem cell transplantation.
Inamoto Y; Nishida T; Suzuki R; Miyamura K; Sao H; Iida H; Naoe T; Maruyama F; Hirabayashi N; Hamaguchi M; Iseki T; Kami M; Yano K; Takeyama H; Morishita Y; Morishima Y; Kodera Y
Bone Marrow Transplant; 2007 Jan; 39(1):25-30. PubMed ID: 17115063
[TBL] [Abstract][Full Text] [Related]
13. Thiotepa-based conditioning versus total body irradiation as myeloablative conditioning prior to allogeneic stem cell transplantation for acute lymphoblastic leukemia: A matched-pair analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Eder S; Canaani J; Beohou E; Labopin M; Sanz J; Arcese W; Or R; Finke J; Cortelezzi A; Beelen D; Passweg J; Socié G; Gurman G; Aljurf M; Stelljes M; Giebel S; Mohty M; Nagler A
Am J Hematol; 2017 Oct; 92(10):997-1003. PubMed ID: 28614903
[TBL] [Abstract][Full Text] [Related]
14. Busulfan and cyclophosphamide as a conditioning regimen for pediatric acute lymphoblastic leukemia patients undergoing bone marrow transplantation.
Shah AJ; Lenarsky C; Kapoor N; Crooks GM; Kohn DB; Parkman R; Epport K; Wilson K; Weinberg K
J Pediatr Hematol Oncol; 2004 Feb; 26(2):91-7. PubMed ID: 14767194
[TBL] [Abstract][Full Text] [Related]
15. A comparison of cyclophosphamide and total body irradiation with etoposide and total body irradiation as conditioning regimens for patients undergoing sibling allografting for acute lymphoblastic leukemia in first or second complete remission.
Marks DI; Forman SJ; Blume KG; Pérez WS; Weisdorf DJ; Keating A; Gale RP; Cairo MS; Copelan EA; Horan JT; Lazarus HM; Litzow MR; McCarthy PL; Schultz KR; Smith DD; Trigg ME; Zhang MJ; Horowitz MM
Biol Blood Marrow Transplant; 2006 Apr; 12(4):438-53. PubMed ID: 16545728
[TBL] [Abstract][Full Text] [Related]
16. Fludarabine, cytarabine, granulocyte colony-stimulating factor and melphalan (FALG with L-PAM) as a reduced toxicity conditioning regimen in children with acute leukemia.
Kato K; Yoshida N; Matsumoto K; Matsuyama T
Pediatr Blood Cancer; 2014 Apr; 61(4):712-6. PubMed ID: 24376191
[TBL] [Abstract][Full Text] [Related]
17. Improved prognosis with additional medium-dose VP16 to CY/TBI in allogeneic transplantation for high risk ALL in adults.
Arai Y; Kondo T; Shigematsu A; Tanaka J; Ohashi K; Fukuda T; Hidaka M; Kobayashi N; Iwato K; Sakura T; Onizuka M; Ozawa Y; Eto T; Kurokawa M; Kahata K; Uchida N; Atsuta Y; Mizuta S; Kako S
Am J Hematol; 2018 Jan; 93(1):47-57. PubMed ID: 28983949
[TBL] [Abstract][Full Text] [Related]
18. Comparative single-institute analysis of cord blood transplantation from unrelated donors with bone marrow or peripheral blood stem-cell transplants from related donors in adult patients with hematologic malignancies after myeloablative conditioning regimen.
Takahashi S; Ooi J; Tomonari A; Konuma T; Tsukada N; Oiwa-Monna M; Fukuno K; Uchiyama M; Takasugi K; Iseki T; Tojo A; Yamaguchi T; Asano S
Blood; 2007 Feb; 109(3):1322-30. PubMed ID: 17038536
[TBL] [Abstract][Full Text] [Related]
19. Excellent outcome of allogeneic hematopoietic stem cell transplantation using a conditioning regimen with medium-dose VP-16, cyclophosphamide and total-body irradiation for adult patients with acute lymphoblastic leukemia.
Shigematsu A; Kondo T; Yamamoto S; Sugita J; Onozawa M; Kahata K; Endo T; Shiratori S; Ota S; Obara M; Wakasa K; Takahata M; Takeda Y; Tanaka J; Hashino S; Nishio M; Koike T; Asaka M; Imamura M
Biol Blood Marrow Transplant; 2008 May; 14(5):568-75. PubMed ID: 18410899
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.
Mori T; Aisa Y; Watanabe R; Yamazaki R; Kato J; Shimizu T; Shigematsu N; Kubo A; Yajima T; Hibi T; Ikeda Y; Okamoto S
Biol Blood Marrow Transplant; 2008 Jun; 14(6):651-7. PubMed ID: 18489990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
